Table 1 Characteristics of MCL patient samples.
From: Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
Patient no. | Age (years) | Gender | Source | Disease status | Morphologic variant | Tumor cells (%)1 |
|---|---|---|---|---|---|---|
1 | 81 | F | Bone marrow | Primary | Blastic | 61.6 |
2 | 58 | F | Bone marrow | Recurrence | Classic | 95.6 |
3 | 77 | F | Peripheral blood | Primary | Blastic | 74.8 |
4 | 75 | F | Bone marrow | Primary | Blastic | 71.1 |
5 | 56 | F | Lymph node | Primary | Classic | 83.0 |
6 | 53 | F | Lymph node | Recurrence | Classic | 88.6 |
7 | 49 | M | Peripheral blood | Primary | Classic | 96.1 |
8 | 57 | F | Bone marrow | Primary | Classic | 83.6 |
9 | 62 | M | Bone marrow | Recurrence | Classic | 76.8 |
10 | 67 | M | Bone marrow | Primary | Classic | 69.7 |